<DOC>
	<DOCNO>NCT01162590</DOCNO>
	<brief_summary>The purpose study assess safety Rotarix ™ administer healthy adult age 18 45 year China .</brief_summary>
	<brief_title>Study Evaluate Reactogenicity Safety Rotarix™ Chinese Adults</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol enrol study . A male female subject Chinese origin , 18 year 45 year inclusive age time vaccination . Written inform consent obtain subject . Healthy subject establish medical history clinical examination enter study . Female subject nonchildbearing potential may enrol study . Female subject childbearing potential may enrol study , subject : practiced adequate contraception 30 day prior vaccination , negative pregnancy test day vaccination , agree continue adequate contraception entire treatment period 2 month completion vaccination . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede dose study vaccine , plan use study period . Acute chronic , clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine medical history , physical examination laboratory test . Any clinically significant history chronic gastrointestinal disease include uncorrected congenital malformation gastrointestinal tract would predispose Intusussception . Gastroenteritis within 7 day precede study vaccine placebo administration . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . History allergic disease reaction likely exacerbate component vaccine . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior vaccination . Planned administration/ administration vaccine foreseen study protocol within 14 day study vaccine placebo end 14 day . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product Administration immunoglobulins and/ blood product within three month precede dose study vaccine plan administration study period . Acute disease time enrolment . Pregnant lactate female . Female plan become pregnant planning discontinue contraceptive precaution . History chronic alcohol consumption and/ drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Human Rotavirus vaccine</keyword>
</DOC>